Ethyl 3-(3-chloro-2,4,5-trifluorophenyl)-3-oxopropanoate

We are Ethyl 3-(3-chloro-2,4,5-trifluorophenyl)-3-oxopropanoate CAS:101987-86-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Ethyl 3-(3-chloro-2,4,5-trifluorophenyl)-3-oxopropanoate
CAS.NO:101987-86-4
Synonyms:Ethyl 3-(3-chloro-2,4,5-trifluorophenyl)-3-oxopropanoate
Benzenepropanoic acid, 3-chloro-2,4,5-trifluoro-β-oxo-, ethyl ester
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 325.3±42.0 °C at 760 mmHg
Melting Point 80-83ºC
Molecular Formula C11H8ClF3O3
Molecular Weight 280.628
Flash Point 130.0±17.0 °C
 
Specification:
Appearance:White to off-white solid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Sitafloxacin and Delafloxacin.

Ethyl 3-(3-chloro-2,4,5-trifluorophenyl)-3-oxopropanoate


Related News: The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.(R, E) -etil 5 – ([1,1'-bifenil] -4-il) -4 – ((terc-butoxicarbonil) amino) -2-metilpent-2-enoato CAS:149709-59-1 The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea CAS:796848-79-8 The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.82357-48-0 According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.

Related Products
Product Name
Propylphosphonic Acid Anhydride View Details
2-(acetylamino)-2-[2-(4-octylphenyl)-2-oxo-ethyl]propanedioic acid diethyl ester View Details
5-[2-(dibenzylamino)acetyl]-2-hydroxybenzamide View Details
L-Valinol manufacturer Fmoc-Prolinol manufacturer 2-Amino-3-nitro-4-picoline manufacturer CAS:8001-54-5;63449-41-2 Cleaner manufacturer (S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid manufacturer